PRKAB1 and Insulin resistance: In addition to the direct regulatory mechanisms of AMPK and SREBP-1C, several downstream mediators of AMPK were reported to suppress the expression of SREBP-1C, leading to inhibited lipid synthesis and insulin resistance (Chyau et al., 2020; Han et al., 2019).